Phillip A. Munoz

Phillip A. Munoz

Auto-generated profile, based on publicly available information

Phillip A. Munoz

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
IBIsabel Blanco
Isabel Blanco
EGElena Gimeno
Elena Gimeno
PMPhillip A. Munoz
Phillip A. Munoz
SPSandra Pizarro
Sandra Pizarro
CGConcepción Gistau
Concepción Gistau
JBJoan Albert Barberà
Joan Albert Barberà
Rationale: Sildenafil, a phosphodiesterase-5 inhibitor, could be useful for treating pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD). However, vasodilators may inhibit hypoxic pulmonary vasoconstriction and impair gas exchange in this condition. Objectives: To assess the acute hemodynamic and gas exchange effects of sildenafil in patients with COPD-associated PH. Methods: We conducted a randomized, dose comparison trial in 20 patients with COPD-associated PH. Eleven patients were assigned to 20 mg, and 9 patients to 40 mg, of sildenafil. Pulmonary hemodynamics and gas exchange, including ventilation–perfusion ( ) relationships, were assessed at rest and during constant-work rate exercise, before and 1 hour after sildenafil administration. Measurements and Main Results: Both sildenafil doses reduced the mean pulmonary arterial pressure (PAP) at rest and during exercise, without differences between them. Overall, PAP decreased −6 mm Hg (95% confidence interval [95% CI], −7 to −4) at rest and −11 mm Hg (95% CI, −14 to −8) during exercise. After sildenafil, PaO2 decreased −6 mm Hg (95% CI, −8 to –4) at rest because of increased perfusion in units with low ratio, without differences between doses. No change in PaO2 (95% CI, −3 to 0.2 mm Hg) or relationships occurred during exercise after sildenafil. Changes induced by sildenafil in PaO2 and distributions at rest correlated with their respective values at baseline. Conclusions: In patients with COPD-associated PH, sildenafil improves pulmonary hemodynamics at rest and during exercise. This effect is accompanied by the inhibition of hypoxic vasoconstriction, which impairs arterial oxygenation at rest. The use of sildenafil in COPD should be done cautiously and under close monitoring of blood gases. Clinical trial registered with www.clinicaltrials.gov (NCT00491803).

1 May 2005 in European Respiratory Journal
Verified
Journal Article
Closed access
GKG. G. King
G. G. King
NBNathan Brown
Nathan Brown
CDC. Diba
C. Diba
CTC. W. Thorpe
C. W. Thorpe
PMP. Muñoz
P. Muñoz
CSC. M. Salome
C. M. Salome
Increased wheeze and asthma diagnosis in obesity may be due to reduced lung volume with subsequent airway narrowing.Asthma (wheeze and airway hyperresponsiveness), functional residual capacity (FRC) and airway conductance (Gaw) were measured in 276 randomly selected subjects aged 28–30 yrs. Data were initially adjusted for smoking and asthma before examining relationships between weight and FRC (after adjustment for height), and between body mass index (BMI = weight·height−2) andGaw(after adjustment for FRC) by multiple linear regression, separately for females and males.For males and females, BMI (±95% confidence interval) was 27.0±4.6 kg·m−2and 25.6±6.0 kg·m−2respectively,Gawwas 0.64±0.04 L·s−1·cmH2O−1and 0.57±0.03 L·s−1·cmH2O−1, and FRC was 85.3±3.4 and 84.0±2.9% of predicted. Weight correlated independently with FRC in males and females. BMI correlated independently and inversely withGawin males, but only weakly in females.In conclusion, obesity is associated with reduced lung volume, which is linked with airway narrowing. However, in males, airway narrowing is greater than that due to reduced lung volume alone. The mechanisms causing airway narrowing and sex differences in obesity are unknown.

23 October 2007 in International Journal of Obesity
Verified
Journal Article
Closed access
CSC M Salome
C M Salome
PMP A Munoz
P A Munoz
NBN Berend
N Berend
CTC W Thorpe
C W Thorpe
LSL M Schachter
L M Schachter
GKG G King
G G King

10 January 2013 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
MDMarita T Dale
Marita T Dale
ZMZoe J McKeough
Zoe J McKeough
PMPhillip A Munoz
Phillip A Munoz
PCPeter Corte
Peter Corte
PBPeter Tp Bye
Peter Tp Bye
JAJennifer A Alison
Jennifer A Alison
Functional exercise capacity in people with asbestos related pleural disease (ARPD) is unknown and there are no data on health-related quality of life (HRQoL). The primary aims were to determine whether functional exercise capacity and HRQoL were reduced in people with ARPD. The secondary aim was to determine whether functional exercise capacity was related to peak exercise capacity, HRQoL, physical activity or respiratory function.

6 August 2012 in Heart
Verified
Journal Article
Closed access
PDF file
SOShamus O'MEagher
Shamus O'MEagher
PMPhillip A Munoz
Phillip A Munoz
JAJennifer A Alison
Jennifer A Alison
IYIven H Young
Iven H Young
DTDavid J Tanous
David J Tanous
RPRajesh Puranik
Rajesh Puranik
Objectives To assess if exercise capacity and resting stroke volume are different in tetralogy of Fallot (TOF) repair survivors with indexed RV (right ventricle) end-diastolic volume (RVEDVi) more versus less than 150 ml/m2, a currently suggested threshold for pulmonary valve replacement (PVR). Design Cross-sectional study. Setting Single-centre adult congenital heart disease unit. Patients 55 consecutively eligible patients with repaired TOF (age at repair 2.3±1.9 years; age at evaluation 26.2±8.8 years; NYHA Class I or II). Interventions Cardiovascular MRI (1.5T) and cardiopulmonary exercise test. Main outcome measures Biventricular volumes and function; exercise capacity. Results 20 patients had RVEDVi below, and 35 had RVEDVi above 150 ml/m2, at time of referral. In the >150 ml/m2 group, fractional pulmonary regurgitation was higher (41±8 vs 31±8%, p<0.001). Although RV ejection fraction (EF) was lower (47±7 vs 54±6%, p=0.007), indexed RV stroke volume was higher (87±14 vs 64±10 ml/m2, p150 ml/m2 group. There were no significant differences in LVEF, indexed LV stroke volume or exercise capacity (% predicted peak work: 90±17 vs 89±11% and; % predicted VO2 peak: 84±17 vs 87±12%). Conclusions Exercise capacity and stroke volume are maintained with RVEDVi above compared with below a commonly used cut-off for PVR surgery. Optimal timing for PVR, thus, remains unclear.

18 November 2014 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
MDMarita T Dale
Marita T Dale
ZMZoe J McKeough
Zoe J McKeough
PMPhillip A Munoz
Phillip A Munoz
PCPeter Corte
Peter Corte
PBPeter T P Bye
Peter T P Bye
JAJennifer A Alison
Jennifer A Alison
The study aimed to determine the short and long-term effects of exercise training on exercise capacity and health-related quality of life (HRQoL) compared to usual care in people with dust-related pleural and interstitial respiratory diseases. No previous studies have specifically evaluated exercise training in this patient population. Participants with a diagnosis of a dust-related respiratory disease including asbestosis and asbestos related pleural disease were recruited and randomised to an eight-week exercise training group (EG) or a control group (CG) of usual care. Six-minute walk distance (6MWD), St George’s Respiratory Questionnaire (SGRQ) and Chronic Respiratory Disease Questionnaire (CRQ) were measured at baseline, eight weeks and 26 weeks by an assessor blinded to group allocation. Thirty-three of 35 male participants completed the study. Sixty-nine percent of participants had asbestos related pleural disease. At eight weeks, compared to the CG, the EG showed a significantly increased 6MWD (mean difference (95%CI)) 53 metres (32 to 74), improved SGRQ total score, -7 points (-13 to -1) and increased CRQ total score, 6.4 points (2.1 to 10.7). At 26 weeks significant between-group differences were maintained in 6MWD, 45 metres (17 to 73) and CRQ total score, 13.1 points (5.2 to 20.9). Exercise training improved short and long-term exercise capacity and HRQoL in people with dust-related pleural and interstitial respiratory diseases. ANZCTR12608000147381 . Date trial registered: 27.03.2008.